Analytics
Doctors are dealing with information overload, but tech could help.
The companies will combine their complementary pathology tools to leverage services for tech-enabled diagnostics, drug discovery and patient care.
The new capital boosts Olive’s valuation to $4 billion.
The industry has accepted that digital is here to stay, with 87% of executives saying their organization’s business and technology strategies are becoming inseparable.
HIMSS21
At HIMSS' State of Healthcare event on June 15, Oscar CEO Mario Schlosser will discuss how the insurance space has adjusted to the COVID-19 demands.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.
HIMSS21
Dr. Jeffrey Vergales, a pediatric cardiologist at UVA Children’s, will be presenting at HIMSS21 on Aug. 10.
The data from PicnicHealth and Komodo's Healthcare Map will be available to researchers in the biopharmaceutical and academic communities.
Also, Genesis MedTech closes Series B funding round.
Eventually, the tracker will be expanded to include conditions such as mental and behavioral health, and include additional determinants of health.